For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Politico
Biden’s got a plan to protect science from Trump
CEI’s Joel Zinberg was cited in Politico on the obstacles Trump faces with the NIH: Trump should have no illusions about what he’s up against,…
Blog
New FDA lab tests rule could bankrupt small labs
Yesterday the Food and Drug Administration (FDA) announced that on May 6 it will promulgate a rule under its authority to regulate medical devices.
National Review
The Return of the Cadillac Tax?
Like the phoenix, a key piece of the Affordable Care Act has risen from the ashes, resurrected, believe it or not, by the Republican Study Committee…
Search Posts
National Review
How Trump Can Help Reopen America’s Schools
It’s almost the middle of August, and many parents still have little idea if their kids will be able to go to school in a few…
The Wall Street Journal
The White House Prepared for a Pandemic
New York Gov. Andrew Cuomo launched the Democrats’ broadside against the Trump administration’s Covid-19 response. “Our current federal government is dysfunctional and incompetent,” he told…
Letters
CEI Joins Coalition Letter Opposing Most Favored Nation Drug Pricing Proposal
On behalf of the undersigned federal and state-based organizations, we write to express our grave concerns with the “most favored nation” (MFN) executive order to impose foreign…
City Journal
Following The Science — Where?
When doctors meet a patient for a new complaint, we make a list of different possible explanations for the problem—a differential diagnosis—and try to determine…
Inside Sources
Government Contact Tracing Won’t Help Get Americans Back to Work, but Innovation Will
Contact tracing identifies people who have an infectious disease (cases) and people they came in contact with (contacts) who may have become infected.
News Release
Price Controls for Medicines Risk Harming Innovation When Breakthrough Drugs or Vaccines May Mean Life or Death
President Trump is expected to issue an executive order today directing his administration to take a series of actions related to pharmaceuticals and the price…